Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MANGOCEUTICALS, INC.MGRX · Entity 8073 | CFO | July 28, 2026 | October 06, 2026 |
| OFA GroupOFAL · Entity 8549 | Chief Financial Officer | October 01, 2026 | October 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MANGOCEUTICALS, INC.
Report date July 28, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 220,000 |
Reported balance
After 2026-07-28 transaction · row 1
1 source rowRow 1 · 2026-07-28 · Grant · Acquired 100,000 · Balance 220,000 F1: Issued in consideration for services rendered as Chief Financial Officer of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued in consideration for services rendered as Chief Financial Officer of the Issuer.
OFA Group
Report date October 01, 2026 · Filed October 09, 2026
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2026 Filed Oct 6, 2026 12:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-045856 · ownership.xml · nonDerivative · entry 1 JOHNSTON EUGENE M · CIK 0001254538 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,000 F1 · price: Issued in consideration for services rendered as Chief Financial Officer of the Issuer. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | SaleCommon Stock | 3,333 | $1.17 | $3,883.94 |
DisclosureSEC source: 0001493152-25-028193 · ownership.xml · nonDerivative · entry 1 JOHNSTON EUGENE M · CIK 0001254538 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 16:05 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | SaleCommon Stock | 5,000 | $1.20 | $5,975.00 |
DisclosureSEC source: 0001493152-25-027238 · ownership.xml · nonDerivative · entry 1 JOHNSTON EUGENE M · CIK 0001254538 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,333 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.19 to $1.21, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 17:16 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | SaleCommon Stock | 10,000 | $1.13 | $11,280.00 |
DisclosureSEC source: 0001493152-25-026923 · ownership.xml · nonDerivative · entry 1 JOHNSTON EUGENE M · CIK 0001254538 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,333 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.10 to $1.20, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 09, 2025 Filed Sep 12, 2025 16:57 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-027218 · ownership.xml · nonDerivative · entry 1 JOHNSTON EUGENE M · CIK 0001254538 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,334 F1 · kind: Issued in consideration for serving as Chief Financial Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan, as amended. Exempt pursuant to Rule 16b-3. F1 · price: Issued in consideration for serving as Chief Financial Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan, as amended. Exempt pursuant to Rule 16b-3. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:06 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-044832 · ownership.xml · nonDerivative · entry 1 JOHNSTON EUGENE M · CIK 0001254538 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,334 F1 · kind: Issued in consideration for serving as Chief Financial Officer of the Issuer. Issued under the registrant's 2022 Equity Incentive Plan, as amended. Exempt pursuant to Rule 16b-3. F1 · price: Issued in consideration for serving as Chief Financial Officer of the Issuer. Issued under the registrant's 2022 Equity Incentive Plan, as amended. Exempt pursuant to Rule 16b-3. Read SEC document |
| October 03, 2023 Filed Oct 4, 2023 16:37 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-035677 · ownership.xml · nonDerivative · entry 1 JOHNSTON EUGENE M · CIK 0001254538 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 F1 · kind: Issued in consideration for serving as Chief Financial Officer of the Issuer. Issued under the registrant's 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Issued in consideration for serving as Chief Financial Officer of the Issuer. Issued under the registrant's 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.